Erythromycin infusions for treatment of infections in the ear, nose and throat region.
Sixteen adult male patients (aged between 20-38 years) with ear, nose and throat infections, caused by bacteria sensitive to erythromycin, received daily infusions of 2 x 1 g erythromycin for 48 hours. The duration of infusion was 30 or 60 minutes, administered at intervals of 12 hours between infusions. Symptoms of intolerance such as nausea, retching, feeling of pressure in epigastric angle as well as abdominal cramps occurred as side-effects in many cases. A spasmolytic was given intravenously to twelve patients; it rapidly eliminated the symptoms. However, these side-effects were considered insignificant compared to the excellent clinical results obtained during infusion therapy. We, therefore, believe that 2 x 1 g/day erythromycin per infusion can be regarded as the drug of choice in chronic and acute ear, nose and throat infections. The rapid resolution of infections, which are otherwise difficult to treat, and the concomitant decrease in confinement to bed by about 8 to 10 days are the most important results in this study.
D000328:Adult; D001424:Bacterial Infections / Q000188:drug therapy*; D004427:Ear Diseases / Q000188:drug therapy*; D004917:Erythromycin / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D010608:Pharyngeal Diseases / Q000188:drug therapy*
D004917:Erythromycin